A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
NCT07318805
This study is recruiting at 13 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer therapies. Anti-cancer therapy is a type of treatment to stop the growth of cancer. This study also aims to find the best amount of study medication. This study is seeking participants that have advanced or metastatic breast cancer (BC), or advanced or metastatic colorectal cancer (CRC). All participants in this study will take the study medication (PF-08032562) as pill by mouth. This will be repeated for 28-day cycles.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Advanced Breast Cancer
- Metastatic Breast Cancer (HR+/ HER2-)
- Colorectal Cancer
- Metastatic Colorectal Adenocarcinoma
- Triple Negative Breast Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Pfizer
- Last updated on ClinicalTrials.gov
- July 22, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center) · Duarte, CA
Michigan · 1
- START Midwest, LLC · Grand Rapids, MI
New York · 4
- Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy · Long Island City, NY
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street). · New York, NY
- Memorial Sloan Kettering Cancer Center - Main Campus · New York, NY
- Memorial Sloan Kettering Cancer Center 53rd street. · New York, NY
Texas · 6
- The University of Texas MD Anderson Cancer Center - Conroe · Conroe, TX
- The University of Texas - M.D. Anderson Cancer Center · Houston, TX
- The University of Texas, MD Anderson Cancer Center - West Houston · Houston, TX
- The University of Texas, MD Anderson Cancer Center - League City · League City, TX
- START San Antonio · San Antonio, TX
- The University of Texas, MD Anderson Cancer Center - Sugar Land · Sugar Land, TX
Utah · 1
- START Mountain Region · West Valley City, UT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.